 | • レポートコード：D0GIR-01885 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、代替部位注入療法の世界市場を広く調査・分析し、今後の市場展望をまとめております。代替部位注入療法の種類別市場規模（静脈内投与、その他非経口経路）、用途別市場規模（癌、慢性疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Option Care Health、PharMerica、HCA Healthcare、Coram CVS、Accredo Health、UnitedHealth Group、CHI Health、McLaren、Cleveland Clinic ・地域別グローバル市場分析 2015年-2020年 ・代替部位注入療法の北米市場（アメリカ、カナダ、メキシコ） ・代替部位注入療法のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・代替部位注入療法のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・代替部位注入療法の南米市場（ブラジル、アルゼンチン） ・代替部位注入療法の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：静脈内投与、その他非経口経路 ・用途別分析：癌、慢性疾患、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Alternate-site Infusion Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Alternate-site Infusion Therapy sales will be xx in 2020 from Alternate-site Infusion Therapy million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Alternate-site Infusion Therapy market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Alternate-site Infusion Therapy industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Alternate-site Infusion Therapy and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Alternate-site Infusion Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Alternate-site Infusion Therapy market has been segmented into:
Administer Drug Intravenously
Other Nnon-oral Routes
By Application, Alternate-site Infusion Therapy has been segmented into:
Cancer
Chronic Disease
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Alternate-site Infusion Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Alternate-site Infusion Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Alternate-site Infusion Therapy market.
The report offers in-depth assessment of the growth and other aspects of the Alternate-site Infusion Therapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Alternate-site Infusion Therapy Market Share Analysis
Alternate-site Infusion Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Alternate-site Infusion Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Alternate-site Infusion Therapy sales, revenue and market share for each player covered in this report.
The major players covered in Alternate-site Infusion Therapy are:
Option Care Health
PharMerica
HCA Healthcare
Coram CVS
Accredo Health
UnitedHealth Group
CHI Health
McLaren
Cleveland Clinic
Among other players domestic and global, Alternate-site Infusion Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Alternate-site Infusion Therapy Market Overview
1.1 Product Overview and Scope of Alternate-site Infusion Therapy
1.2 Classification of Alternate-site Infusion Therapy by Type
1.2.1 Global Alternate-site Infusion Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Alternate-site Infusion Therapy Revenue Market Share by Type in 2019
1.2.3 Administer Drug Intravenously
1.2.4 Other Nnon-oral Routes
1.3 Global Alternate-site Infusion Therapy Market by Application
1.3.1 Overview: Global Alternate-site Infusion Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer
1.3.3 Chronic Disease
1.3.4 Others
1.4 Global Alternate-site Infusion Therapy Market by Regions
1.4.1 Global Alternate-site Infusion Therapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Alternate-site Infusion Therapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Alternate-site Infusion Therapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Alternate-site Infusion Therapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Alternate-site Infusion Therapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Alternate-site Infusion Therapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Alternate-site Infusion Therapy Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Alternate-site Infusion Therapy Industry Impact
1.5.1 COVID-19 Potential Implications for the Alternate-site Infusion Therapy
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Alternate-site Infusion Therapy
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Option Care Health
2.1.1 Option Care Health Details
2.1.2 Option Care Health Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Option Care Health SWOT Analysis
2.1.4 Option Care Health Product and Services
2.1.5 Option Care Health Alternate-site Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 PharMerica
2.2.1 PharMerica Details
2.2.2 PharMerica Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 PharMerica SWOT Analysis
2.2.4 PharMerica Product and Services
2.2.5 PharMerica Alternate-site Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 HCA Healthcare
2.3.1 HCA Healthcare Details
2.3.2 HCA Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 HCA Healthcare SWOT Analysis
2.3.4 HCA Healthcare Product and Services
2.3.5 HCA Healthcare Alternate-site Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Coram CVS
2.4.1 Coram CVS Details
2.4.2 Coram CVS Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Coram CVS SWOT Analysis
2.4.4 Coram CVS Product and Services
2.4.5 Coram CVS Alternate-site Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Accredo Health
2.5.1 Accredo Health Details
2.5.2 Accredo Health Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Accredo Health SWOT Analysis
2.5.4 Accredo Health Product and Services
2.5.5 Accredo Health Alternate-site Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 UnitedHealth Group
2.6.1 UnitedHealth Group Details
2.6.2 UnitedHealth Group Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 UnitedHealth Group Product and Services
2.6.4 UnitedHealth Group Alternate-site Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 CHI Health
2.7.1 CHI Health Details
2.7.2 CHI Health Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 CHI Health Product and Services
2.7.4 CHI Health Alternate-site Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 McLaren
2.8.1 McLaren Details
2.8.2 McLaren Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 McLaren Product and Services
2.8.4 McLaren Alternate-site Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.9 Cleveland Clinic
2.9.1 Cleveland Clinic Details
2.9.2 Cleveland Clinic Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Cleveland Clinic Product and Services
2.9.4 Cleveland Clinic Alternate-site Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Alternate-site Infusion Therapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Alternate-site Infusion Therapy Players Market Share
3.2.2 Top 10 Alternate-site Infusion Therapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Alternate-site Infusion Therapy Revenue and Market Share by Regions
4.2 North America Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
4.3 Europe Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
4.5 South America Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
5 North America Alternate-site Infusion Therapy Revenue by Countries
5.1 North America Alternate-site Infusion Therapy Revenue by Countries (2015-2020)
5.2 USA Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
5.3 Canada Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
6 Europe Alternate-site Infusion Therapy Revenue by Countries
6.1 Europe Alternate-site Infusion Therapy Revenue by Countries (2015-2020)
6.2 Germany Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
6.3 UK Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
6.4 France Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
6.5 Russia Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
6.6 Italy Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Alternate-site Infusion Therapy Revenue by Countries
7.1 Asia-Pacific Alternate-site Infusion Therapy Revenue by Countries (2015-2020)
7.2 China Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
7.3 Japan Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
7.4 Korea Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
7.5 India Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
8 South America Alternate-site Infusion Therapy Revenue by Countries
8.1 South America Alternate-site Infusion Therapy Revenue by Countries (2015-2020)
8.2 Brazil Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Alternate-site Infusion Therapy by Countries
9.1 Middle East & Africa Alternate-site Infusion Therapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
9.3 UAE Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Alternate-site Infusion Therapy Revenue and Market Share by Type (2015-2020)
10.2 Global Alternate-site Infusion Therapy Market Forecast by Type (2019-2024)
10.3 Administer Drug Intravenously Revenue Growth Rate (2015-2025)
10.4 Other Nnon-oral Routes Revenue Growth Rate (2015-2025)
11 Global Alternate-site Infusion Therapy Market Segment by Application
11.1 Global Alternate-site Infusion Therapy Revenue Market Share by Application (2015-2020)
11.2 Alternate-site Infusion Therapy Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2015-2020)
11.4 Chronic Disease Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Alternate-site Infusion Therapy Market Size Forecast (2021-2025)
12.1 Global Alternate-site Infusion Therapy Market Size Forecast (2021-2025)
12.2 Global Alternate-site Infusion Therapy Market Forecast by Regions (2021-2025)
12.3 North America Alternate-site Infusion Therapy Revenue Market Forecast (2021-2025)
12.4 Europe Alternate-site Infusion Therapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Alternate-site Infusion Therapy Revenue Market Forecast (2021-2025)
12.6 South America Alternate-site Infusion Therapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Alternate-site Infusion Therapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Alternate-site Infusion Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Alternate-site Infusion Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Alternate-site Infusion Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Alternate-site Infusion Therapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Alternate-site Infusion Therapy Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Option Care Health Corporate Information, Location and Competitors
Table 7. Option Care Health Alternate-site Infusion Therapy Major Business
Table 8. Option Care Health Alternate-site Infusion Therapy Total Revenue (USD Million) (2017-2018)
Table 9. Option Care Health SWOT Analysis
Table 10. Option Care Health Alternate-site Infusion Therapy Product and Solutions
Table 11. Option Care Health Alternate-site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. PharMerica Corporate Information, Location and Competitors
Table 13. PharMerica Alternate-site Infusion Therapy Major Business
Table 14. PharMerica Alternate-site Infusion Therapy Total Revenue (USD Million) (2018-2019)
Table 15. PharMerica SWOT Analysis
Table 16. PharMerica Alternate-site Infusion Therapy Product and Solutions
Table 17. PharMerica Alternate-site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. HCA Healthcare Corporate Information, Location and Competitors
Table 19. HCA Healthcare Alternate-site Infusion Therapy Major Business
Table 20. HCA Healthcare Alternate-site Infusion Therapy Total Revenue (USD Million) (2017-2018)
Table 21. HCA Healthcare SWOT Analysis
Table 22. HCA Healthcare Alternate-site Infusion Therapy Product and Solutions
Table 23. HCA Healthcare Alternate-site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Coram CVS Corporate Information, Location and Competitors
Table 25. Coram CVS Alternate-site Infusion Therapy Major Business
Table 26. Coram CVS Alternate-site Infusion Therapy Total Revenue (USD Million) (2017-2018)
Table 27. Coram CVS SWOT Analysis
Table 28. Coram CVS Alternate-site Infusion Therapy Product and Solutions
Table 29. Coram CVS Alternate-site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Accredo Health Corporate Information, Location and Competitors
Table 31. Accredo Health Alternate-site Infusion Therapy Major Business
Table 32. Accredo Health Alternate-site Infusion Therapy Total Revenue (USD Million) (2017-2018)
Table 33. Accredo Health SWOT Analysis
Table 34. Accredo Health Alternate-site Infusion Therapy Product and Solutions
Table 35. Accredo Health Alternate-site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. UnitedHealth Group Corporate Information, Location and Competitors
Table 37. UnitedHealth Group Alternate-site Infusion Therapy Major Business
Table 38. UnitedHealth Group Alternate-site Infusion Therapy Total Revenue (USD Million) (2017-2018)
Table 39. UnitedHealth Group SWOT Analysis
Table 40. UnitedHealth Group Alternate-site Infusion Therapy Product and Solutions
Table 41. UnitedHealth Group Alternate-site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. CHI Health Corporate Information, Location and Competitors
Table 43. CHI Health Alternate-site Infusion Therapy Major Business
Table 44. CHI Health Alternate-site Infusion Therapy Total Revenue (USD Million) (2017-2018)
Table 45. CHI Health SWOT Analysis
Table 46. CHI Health Alternate-site Infusion Therapy Product and Solutions
Table 47. CHI Health Alternate-site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. McLaren Corporate Information, Location and Competitors
Table 49. McLaren Alternate-site Infusion Therapy Major Business
Table 50. McLaren Alternate-site Infusion Therapy Total Revenue (USD Million) (2017-2018)
Table 51. McLaren SWOT Analysis
Table 52. McLaren Alternate-site Infusion Therapy Product and Solutions
Table 53. McLaren Alternate-site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Cleveland Clinic Corporate Information, Location and Competitors
Table 55. Cleveland Clinic Alternate-site Infusion Therapy Major Business
Table 56. Cleveland Clinic Alternate-site Infusion Therapy Total Revenue (USD Million) (2017-2018)
Table 57. Cleveland Clinic SWOT Analysis
Table 58. Cleveland Clinic Alternate-site Infusion Therapy Product and Solutions
Table 59. Cleveland Clinic Alternate-site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Global Alternate-site Infusion Therapy Revenue (Million USD) by Players (2015-2020)
Table 61. Global Alternate-site Infusion Therapy Revenue Share by Players (2015-2020)
Table 62. Global Alternate-site Infusion Therapy Revenue (Million USD) by Regions (2015-2020)
Table 63. Global Alternate-site Infusion Therapy Revenue Market Share by Regions (2015-2020)
Table 64. North America Alternate-site Infusion Therapy Revenue by Countries (2015-2020)
Table 65. North America Alternate-site Infusion Therapy Revenue Market Share by Countries (2015-2020)
Table 66. Europe Alternate-site Infusion Therapy Revenue (Million USD) by Countries (2015-2020)
Table 67. Asia-Pacific Alternate-site Infusion Therapy Revenue (Million USD) by Countries (2015-2020)
Table 68. South America Alternate-site Infusion Therapy Revenue by Countries (2015-2020)
Table 69. South America Alternate-site Infusion Therapy Revenue Market Share by Countries (2015-2020)
Table 70. Middle East and Africa Alternate-site Infusion Therapy Revenue (Million USD) by Countries (2015-2020)
Table 71. Middle East and Africa Alternate-site Infusion Therapy Revenue Market Share by Countries (2015-2020)
Table 72. Global Alternate-site Infusion Therapy Revenue (Million USD) by Type (2015-2020)
Table 73. Global Alternate-site Infusion Therapy Revenue Share by Type (2015-2020)
Table 74. Global Alternate-site Infusion Therapy Revenue Forecast by Type (2021-2025)
Table 75. Global Alternate-site Infusion Therapy Revenue by Application (2015-2020)
Table 76. Global Alternate-site Infusion Therapy Revenue Share by Application (2015-2020)
Table 77. Global Alternate-site Infusion Therapy Revenue Forecast by Application (2021-2025)
Table 78. Global Alternate-site Infusion Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Alternate-site Infusion Therapy Picture
Figure 2. Global Alternate-site Infusion Therapy Revenue Market Share by Type in 2019
Figure 3. Administer Drug Intravenously Picture
Figure 4. Other Nnon-oral Routes Picture
Figure 5. Alternate-site Infusion Therapy Revenue Market Share by Application in 2019
Figure 6. Cancer Picture
Figure 7. Chronic Disease Picture
Figure 8. Others Picture
Figure 9. Global Alternate-site Infusion Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Alternate-site Infusion Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Alternate-site Infusion Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Alternate-site Infusion Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Alternate-site Infusion Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Alternate-site Infusion Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Alternate-site Infusion Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Alternate-site Infusion Therapy Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Alternate-site Infusion Therapy Revenue Market Share in 2019
Figure 18. Global Top 10 Players Alternate-site Infusion Therapy Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Alternate-site Infusion Therapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Alternate-site Infusion Therapy Revenue Market Share by Regions (2015-2020)
Figure 22. Global Alternate-site Infusion Therapy Revenue Market Share by Regions in 2018
Figure 23. North America Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 24. Europe Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 26. South America Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 28. North America Alternate-site Infusion Therapy Revenue Market Share by Countries (2015-2020)
Figure 29. North America Alternate-site Infusion Therapy Revenue Market Share by Countries in 2019
Figure 30. USA Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 31. Canada Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 33. Europe Alternate-site Infusion Therapy Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Alternate-site Infusion Therapy Revenue Market Share by Countries in 2019
Figure 35. Germany Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 36. UK Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 37. France Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 38. Russia Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 39. Italy Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Alternate-site Infusion Therapy Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Alternate-site Infusion Therapy Revenue Market Share by Countries in 2019
Figure 42. China Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 43. Japan Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 44. Korea Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 45. India Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 47. South America Alternate-site Infusion Therapy Revenue Market Share by Countries (2015-2020)
Figure 48. South America Alternate-site Infusion Therapy Revenue Market Share by Countries in 2019
Figure 49. Brazil Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Alternate-site Infusion Therapy Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Alternate-site Infusion Therapy Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 54. UAE Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Alternate-site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 57. Global Alternate-site Infusion Therapy Revenue Share by Type (2015-2020)
Figure 58. Global Alternate-site Infusion Therapy Revenue Share by Type in 2019
Figure 59. Global Alternate-site Infusion Therapy Market Share Forecast by Type (2021-2025)
Figure 60. Global Administer Drug Intravenously Revenue Growth Rate (2015-2020)
Figure 61. Global Other Nnon-oral Routes Revenue Growth Rate (2015-2020)
Figure 62. Global Alternate-site Infusion Therapy Revenue Share by Application (2015-2020)
Figure 63. Global Alternate-site Infusion Therapy Revenue Share by Application in 2019
Figure 64. Global Alternate-site Infusion Therapy Market Share Forecast by Application (2021-2025)
Figure 65. Global Cancer Revenue Growth Rate (2015-2020)
Figure 66. Global Chronic Disease Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Alternate-site Infusion Therapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Alternate-site Infusion Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Alternate-site Infusion Therapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Alternate-site Infusion Therapy Revenue Market Forecast (2021-2025)
Figure 72. Europe Alternate-site Infusion Therapy Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Alternate-site Infusion Therapy Revenue Market Forecast (2021-2025)
Figure 74. South America Alternate-site Infusion Therapy Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Alternate-site Infusion Therapy Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
がん輸液療法の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Cancer Infusion Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…- 外来輸液療法サービスの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Outpatient Infusion Therapy Service market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- 外来輸液療法の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Ambulatory Infusion Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 家庭用輸液療法デバイスの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Home Infusion Therapy Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.9% in the forecast period of 2020 to 2025 and will expected to reach USD 22150 million by 2025, from USD 19050 million in 2019. The Home Inf…
- 代替リレーの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Alternate Relay market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Alternate Relay market report…